Anixa Biosciences (ANIX) Expected to Announce Earnings on Tuesday

Anixa Biosciences (NASDAQ:ANIX) is projected to release its Q2 2025 earnings data before the market opens on Tuesday, June 3rd. Analysts expect Anixa Biosciences to post earnings of ($0.10) per share for the quarter.

Anixa Biosciences (NASDAQ:ANIX) last posted its quarterly earnings data on Tuesday, March 11th. The company reported ($0.10) EPS for the quarter, hitting analysts’ consensus estimates of ($0.10).

Anixa Biosciences Trading Down 3.8%

Anixa Biosciences stock opened at $2.50 on Tuesday. The stock has a market cap of $80.49 million, a PE ratio of -6.41 and a beta of 0.43. The stock has a 50-day moving average price of $2.72 and a 200 day moving average price of $2.82. Anixa Biosciences has a 52 week low of $2.07 and a 52 week high of $4.20.

Analysts Set New Price Targets

A number of research firms recently commented on ANIX. D. Boral Capital reiterated a “buy” rating and set a $10.00 price objective on shares of Anixa Biosciences in a research report on Thursday, April 10th. HC Wainwright restated a “buy” rating and issued a $7.00 price target on shares of Anixa Biosciences in a report on Tuesday, March 25th. Finally, Maxim Group began coverage on Anixa Biosciences in a report on Friday, March 21st. They issued a “buy” rating and a $10.00 price target for the company.

Anixa Biosciences Company Profile

Anixa Biosciences, Inc, a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer.